Posts

Biogen indicated it has terminated an observational study of its approved Alzheimer’s drug Aduhelm (aducanumab-avwa) following its post on ClinicalTrials.gov.

A bipartisan bill introduced by the leaders of the Senate Diabetes Caucus aims to curb the pricing of life-saving insulin by capping monthly co-pays for diabetics who use both commercial insurance plans, as well as the government-backed Medicare.

The U.S. Supreme Court on Tuesday declined to hear UnitedHealth Group Inc’s challenge to a government rule requiring private insurers that administer federally funded Medicare plans to return potentially billions of dollars in overpayments they receive based on incorrect diagnoses.

The U.S. Supreme Court on Wednesday ruled in favor of a group of nonprofit hospitals in their bid to restore billions of dollars cut by the government from their annual Medicare reimbursements since 2018.

A slowdown in healthcare spending has shored up the funding outlook for the federal program that pays elderly Americans’ hospital bills, trustees of the program said on Wednesday. The Medicare program’s trust fund for hospital care will run out of money in 2030 the trustees said in a report. That was the same year as […]